Seminars
Feb 9, 2026
AI-driven live-cell pharmacopathology: a new paradigm for natural product discovery and precision oncology
Speaker: Professor Laszlo Szekely
Department of Laboratory Medicine, Karolinska Institut
School of Biomedical Sciences cordially invites you to join the following seminar:
Date: 9 February 2026 (Monday)
Time: 12:30 pm – 1:30 pm
Venue: Lecture Theatre 1, G/F, William M.W. Mong Block, 21 Sassoon Road
Host: Professor Guoping Fan
Biography
Laszlo Szekely is Professor of Pathology and Oncology at Karolinska Institutet as well as a foreign adjunct professor at The Chinese University of Hong Kong, Shenzhen. He is also an invited expert for the National Working Group of Genomic Medicine Sweden. Additionally, he serves as the head of the Department of Pathology and the Drug Trial Department at Karolinska Hospital. He played a key role in setting up the Karolinska Visualization Core Facility (KIVIF), where he acts as a senior technical consultant. His extensive expertise in the interdisciplinary fields of spatiotemporal pathology and artificial intelligence has enabled him to successfully translate numerous achievements into clinical applications.
Abstract
This framework overcomes the limitations of static pathology by integrating dynamic, primary live-cell phenotypic screening with AI-powered multimodal data fusion. It continuously monitors drug response within preserved tumor microenvironments, capturing therapeutic heterogeneity. AI analyses this real-time phenotypic data alongside multi-omics and pharmacological profiles to construct predictive spatiotemporal networks. This approach automates the elucidation of complex, multi-target mechanisms - particularly transformative for natural product development. It decodes the polypharmacology of traditional medicines, translating empirical clinical knowledge into digitized, interpretable, and actionable strategies for personalized cancer therapy and complex disease management.
New Releases
Nov 25, 2025
HKUMed cracks gastric cancer’s ‘metabolic code’: Tumour growth slowed by 65%, plus a 6.3-fold kill rate with cholesterol inhibitors in neuron-infiltrated cases
Nov 6, 2025
From genes to face and skull: HKUMed uncovers key causes of congenital craniofacial abnormalities to improve prenatal detection of cleft lip and skull malformations
Aug 12, 2025
HKUMed identifies key protein in liver cancer resistance and develops inhibitor to enhance therapy and prevent cancer recurrence
Jun 24, 2025